The FDA has approved Repatha ... NCT02624869) that evaluated the efficacy and safety of evolocumab 420mg subcutaneously once monthly in patients 10 to 17 years of age with HoFH.

Amgen said it will sell the cholesterol drug Repatha only at a list price 60% lower than its original price in a bid to make the medicine more affordable for patients and kick-start sales.

With the release of the FOURIER trial, Amgen and academic investigators have provided evidence that their novel cholesterol-reducing drug, Repatha (evolcumab), can reduce risk. Among people with ...

Amgen announced the submission of an application to the Food and Drug Administration (FDA) seeking approval of a single-injection option for the monthly administration of the 420mg dose of Repatha ...

In March 2015, Amgen is preparing for the launch of Repatha, a new molecule that has demonstrated a remarkable ability to treat high cholesterol. Through a series of clinical trials, Amgen has proven ...

In 2016, Amgen (AMGN) expects Repatha, a novel PCSK9 inhibitor drug, to continue to capture global market share in the atherosclerosis segment.

Amgen Inc.AMGN-1.86%decrease; red down pointing triangle on Friday reported widely anticipated data on its new cholesterol-lowering drug Repatha, showing it reduced the risk of deaths, heart ...

Regeneron (NASDAQ:REGN) won $135.6M in compensatory damages and $271.2M in punitive damages.Praluent, a PCSK9 inhibitor developed by Regeneron (NASDAQ:REGN) and Sanofi under a global collaboration ...

Amgen may face yet another setback with its controversial Repatha cholesterol-lowering drug because an influential nonprofit may soon lower its value rating for the medicine. In a new report, the ...

Repatha costs $14,000 a year and insurers often won’t pay. It is given as a do-it-yourself shot using a pen-like device, to be taken every two weeks, or once a month.

Rosie O’Donnell showed off her new slimmer body in an Instagram photo on May 23 "I can't believe this is me now," the comedian wrote. She revealed in January 2023 that her doctor had put her on ...

Shares of Amgen, Inc. (NASDAQ: AMGN ) fell 7 percent after the biotechnology company released data from its therapy called Repatha , which is used to lower the risk of heart attacks, strokes and ...